{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:47:04Z","timestamp":1791208024186,"version":"4.1.0"},"reference-count":143,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"DOI":"10.3389\/fvets.2019.00507","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T04:34:46Z","timestamp":1579581286000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses"],"prefix":"10.3389","volume":"6","author":[{"given":"Elizabeth S.","family":"MacDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer G.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"p. 3","DOI":"10.1007\/978-94-007-6716-4_1","article-title":"A historical overview and concepts of mesenchymal stem cells","volume-title":"Essentials of Mesenchymal Stem Cell Biology and Its Clinical Translation","author":"Wang","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.tvjl.2012.06.004","article-title":"Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources","volume":"195","author":"Burk","year":"2013","journal-title":"Vet J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbrc.2007.07.182","article-title":"Characterization and differentiation of equine umbilical cord-derived matrix cells","volume":"362","author":"Hoynowski","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.vetimm.2011.06.033","article-title":"Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue","volume":"144","author":"Ranera","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/scrt414","article-title":"Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential","volume":"5","author":"Barberini","year":"2014","journal-title":"Stem Cell Res Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2460\/ajvr.68.10.1095","article-title":"Isolation and characterization of bone marrow-derived equine mesenchymal stem cells","volume":"68","author":"Arnhold","year":"2007","journal-title":"Am J Vet Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/scrt402","article-title":"Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro","volume":"5","author":"Schnabel","year":"2014","journal-title":"Stem Cell Res Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.vetimm.2009.06.014","article-title":"Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue","volume":"132","author":"de Mattos Carvalho","year":"2009","journal-title":"Vet Immunol Immunopathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.theriogenology.2010.11.008","article-title":"Markers of stemness in equine mesenchymal stem cells: a plea for uniformity","volume":"75","author":"De Schauwer","year":"2011","journal-title":"Theriogenology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cll.2010.12.001","article-title":"The regenerative medicine laboratory: facilitating stem cell therapy for equine disease","volume":"31","author":"Borjesson","year":"2011","journal-title":"Clin Lab Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/ten.teb.2016.0365","article-title":"Trophic effects of mesenchymal stem cells in tissue regeneration","volume":"23","author":"Fu","year":"2017","journal-title":"Tissue Eng Part B Rev"},{"key":"B13","first-page":"207","article-title":"Immunomodulation by mesenchymal stem cells in veterinary species","volume":"63","author":"Carrade","year":"2013","journal-title":"Comp Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.autrev.2011.01.005","article-title":"Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases","volume":"10","author":"Ben-Ami","year":"2011","journal-title":"Autoimmun Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","article-title":"Mesenchymal stromal cells and the innate immune response","volume":"168","author":"Le Blanc","year":"2015","journal-title":"Immunol Lett."},{"key":"B16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","article-title":"Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion","volume":"3","author":"Eggenhofer","year":"2012","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/stem.2779","article-title":"Immunomodulation by therapeutic Mesenchymal Stromal Cells (MSC) is triggered through phagocytosis of MSC by monocytic cells","volume":"36","author":"de Witte","year":"2018","journal-title":"Stem Cells."},{"key":"B18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cveq.2011.06.004","article-title":"Mesenchymal stem cells: characteristics, sources, and mechanisms of action","volume":"27","author":"Stewart","year":"2011","journal-title":"Vet Clin North Am Equine Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13287-018-0849-6","article-title":"Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses","volume":"9","author":"Barberini","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1517\/14712590903321439","article-title":"Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases","volume":"9","author":"Sadan","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10557-011-6311-y","article-title":"Mesenchymal stem cells for cardiovascular regeneration","volume":"25","author":"Kuraitis","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cveq.2011.06.003","article-title":"Anti-inflammatory and immunomodulatory activities of stem cells","volume":"27","author":"Peroni","year":"2011","journal-title":"Vet Clin North Am Equine Pract"},{"key":"B23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/14653249.2010.536213","article-title":"Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses","volume":"13","author":"Carrade","year":"2011","journal-title":"Cytotherapy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2460\/ajvr.78.7.867","article-title":"Antigenicity of mesenchymal stem cells in an inflamed joint environment","volume":"78","author":"Hill","year":"2017","journal-title":"Am J Vet Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","article-title":"How mesenchymal stem cells interact with tissue immune responses","volume":"33","author":"Shi","year":"2012","journal-title":"Trends Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","article-title":"Mesenchymal stem cells: mechanisms of inflammation","volume":"6","author":"Singer","year":"2011","journal-title":"Ann Rev Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1097\/TP.0b013e3181a285b0","article-title":"The immunosuppressive properties of mesenchymal stem cells","volume":"87","author":"Siegel","year":"2009","journal-title":"Transplantation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.biochi.2013.06.017","article-title":"Uncovering the secretes of mesenchymal stem cells","volume":"95","author":"Lavoie","year":"2013","journal-title":"Biochimie."},{"key":"B29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cellimm.2010.06.006","article-title":"Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources","volume":"264","author":"Najar","year":"2010","journal-title":"Cell Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/evj.12414","article-title":"Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes","volume":"48","author":"Ranera","year":"2016","journal-title":"Equine Vet J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/scd.2016.0266","article-title":"Autologous and allogeneic equine mesenchymal stem cells exhibit equivalent immunomodulatory properties in vitro","volume":"26","author":"Colbath","year":"2017","journal-title":"Stem Cells Dev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1365-3083.2007.01905.x","article-title":"Mesenchymal stem cells stimulate antibody secretion in human B cells. Scandinavian journal of immunology","volume":"65","author":"Rasmusson","year":"2007","journal-title":"Scand J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3324\/haematol.12857","article-title":"The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes","volume":"93","author":"Tabera","year":"2008","journal-title":"Haematologica."},{"key":"B34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1182\/blood-2008-04-154138","article-title":"Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3727\/215517912X647217","article-title":"Comparative analysis of the immunomodulatory properties of equine adult-derived mesenchymal stem cells","volume":"4","author":"Carrade","year":"2012","journal-title":"Cell Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","article-title":"Mechanisms involved in the therapeutic properties of mesenchymal stem cells","volume":"20","author":"Meirelles Lda","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"C675","DOI":"10.1152\/ajpcell.00437.2007","article-title":"Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism","volume":"294","author":"Crisostomo","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2213","DOI":"10.1371\/journal.pone.0002213","article-title":"Replicative senescence of mesenchymal stem cells: a continuous and organized process","volume":"3","author":"Wagner","year":"2008","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jcyt.2013.11.008","article-title":"Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-\u03b3 and tumor necrosis factor-\u03b1 stimulation","volume":"16","author":"Cuerquis","year":"2014","journal-title":"Cytotherapy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/scd.2016.0209","article-title":"Priming equine bone marrow-derived mesenchymal stem cells with proinflammatory cytokines: implications in immunomodulation-immunogenicity balance, cell viability, and differentiation potential","volume":"26","author":"Barrachina","year":"2017","journal-title":"Stem Cells Dev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vetimm.2016.02.007","article-title":"Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties","volume":"171","author":"Barrachina","year":"2016","journal-title":"Vet Immunol Immunopathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.vetimm.2017.10.003","article-title":"The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand","volume":"195","author":"Cassano","year":"2018","journal-title":"Vet Immunol Immunopathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13287-018-0840-2","article-title":"Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment","volume":"9","author":"Cassano","year":"2018","journal-title":"Stem Cell Res Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fvets.2017.00084","article-title":"Transforming growth factor-beta2 downregulates Major Histocompatibility Complex (MHC) I and MHC II surface expression on equine bone marrow-derived mesenchymal stem cells without altering other phenotypic cell surface markers","volume":"4","author":"Berglund","year":"2017","journal-title":"Front Vet Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4142\/jvs.2017.18.1.39","article-title":"Inflammation affects the viability and plasticity of equine mesenchymal stem cells: possible implications in intra-articular treatments","volume":"18","author":"Barrachina","year":"2017","journal-title":"J Vet Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1089\/scd.2013.0537","article-title":"Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source","volume":"23","author":"Carrade Holt","year":"2014","journal-title":"Stem Cells Dev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2174\/092986708784872393","article-title":"Human endotoxemia as a model of systemic inflammation","volume":"15","author":"Andreasen","year":"2008","journal-title":"Curr Med Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1378\/chest.99.1.169","article-title":"Endotoxemia in human septic shock","volume":"99","author":"Danner","year":"1991","journal-title":"Chest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0167-5877(00)00193-8","article-title":"Factor analysis of the interrelationships between clinical variables in horses with colic","volume":"48","author":"Thoefner","year":"2001","journal-title":"Prevent Vet Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.2042-3306.1997.tb03157.x","article-title":"Prospective study of equine colic incidence and mortality","volume":"29","author":"Tinker","year":"1997","journal-title":"Equine Vet J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.2042-3306.2010.00328.x","article-title":"Plasma endotoxin in horses presented to an equine referral hospital: correlation to selected clinical parameters and outcomes","volume":"43","author":"Senior","year":"2011","journal-title":"Equine Vet J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/01652176.1994.9694517","article-title":"Laboratory and clinical evaluation of a chromogenic endotoxin assay for horses with acute intestinal disorders","volume":"16","author":"Steverink","year":"1994","journal-title":"Vet Q"},{"key":"B53","doi-asserted-by":"crossref","first-page":"p. 104","DOI":"10.1016\/B978-0-7216-9540-2.50034-7","article-title":"Endotoxemia","volume-title":"Robinson's Current Therapy in Equine Medicine.","author":"Barton","year":"2003"},{"key":"B54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2460\/ajvr.1991.52.04.533","article-title":"Tumor necrosis factor activity in the circulation of horses given endotoxin","volume":"52","author":"MacKay","year":"1991","journal-title":"Am J Vet Res."},{"key":"B55","first-page":"p. 638","volume-title":"Diseases of the Equine Alimentary Tract. Large Animal Internal Medicine.","author":"Jones","year":"2015"},{"key":"B56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1939-1676.1991.tb00944.x","article-title":"Endotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis","volume":"5","author":"Morris","year":"1991","journal-title":"J Vet Intern Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.2042-3306.1986.tb03623.x","article-title":"Incidence, diagnosis and treatment of postoperative complications in colic cases","volume":"18","author":"Hunt","year":"1986","journal-title":"Equine Vet J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"L131","DOI":"10.1152\/ajplung.00431.2006","article-title":"Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice","volume":"293","author":"Xu","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd1854","article-title":"Animal models of sepsis: setting the stage","volume":"4","author":"Buras","year":"2005","journal-title":"Nat Rev Drug Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis","volume":"182","author":"Mei","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/gut.2008.168534","article-title":"Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis","volume":"58","author":"Gonzalez-Rey","year":"2009","journal-title":"Gut."},{"key":"B62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nat Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13287-017-0610-6","article-title":"Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds","volume":"8","author":"Harman","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.1038\/s41598-017-08311-4","article-title":"Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections","volume":"7","author":"Johnson","year":"2017","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e17850","DOI":"10.7554\/eLife.17850.023","article-title":"Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial","volume":"5","author":"Lalu","year":"2016","journal-title":"Elife"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1089\/scd.2016.0184","article-title":"Effect of mesenchymal stromal cells on t cells in a septic context: immunosuppression or immunostimulation?","volume":"26","author":"Le Burel","year":"2017","journal-title":"Stem Cells Dev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1164\/rccm.201705-1006OC","article-title":"Cellular immunotherapy for septic shock. A phase I clinical trial","volume":"197","author":"McIntyre","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/stem.2891","article-title":"Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group, placebo controlled trial","volume":"36","author":"Perlee","year":"2018","journal-title":"Stem Cells."},{"key":"B69","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/jamp.2009.0775","article-title":"Acute lung injury: epidemiology, pathogenesis, and treatment","volume":"23","author":"Johnson","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J Clin Invest"},{"key":"B71","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1939-1676.1993.tb01020.x","article-title":"Bronchointerstitial pneumonia and respiratory distress in young horses: clinical, clinicopathologic, radiographic, and pathological findings in 23 cases (1984-1989)","volume":"7","author":"Lakritz","year":"1993","journal-title":"J Vet Intern Med"},{"key":"B72","first-page":"p. 461","article-title":"Diseases of the respiratory system","volume-title":"Large Animal Internal Medicine","author":"Dunkel","year":"2015"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","article-title":"Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice","volume":"179","author":"Gupta","year":"2007","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1378\/chest.11-0539","article-title":"IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice","volume":"140","author":"Yang","year":"2011","journal-title":"Chest."},{"key":"B75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/scrt430","article-title":"Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep","volume":"5","author":"Rojas","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"B76","doi-asserted-by":"publisher","first-page":"E689","DOI":"10.3390\/ijms18040689","article-title":"Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury","volume":"18","author":"Xiang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/jvim.13824","article-title":"Inflammatory airway disease of horses\u2014revised consensus statement","volume":"30","author":"Cou\u00ebtil","year":"2016","journal-title":"J Vet Intern Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0749-0739(02)00067-6","article-title":"Recurrent airway obstruction\u2013heaves","volume":"19","author":"Leguillette","year":"2003","journal-title":"Vet Clin North Am Equine Pract"},{"key":"B79","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/evj.12204","article-title":"Recurrent airway obstruction: a review","volume":"46","author":"Pirie","year":"2014","journal-title":"Equine Vet J"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0749-0739(17)30115-3","article-title":"Equine T-cell cytokines. Protection and pathology","volume":"16","author":"Horohov","year":"2000","journal-title":"Vet Clin North Am Equine Pract"},{"key":"B81","doi-asserted-by":"publisher","first-page":"L760","DOI":"10.1152\/ajplung.00182.2009","article-title":"Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model","volume":"299","author":"Bonfield","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1073\/pnas.0910720107","article-title":"Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma","volume":"107","author":"Nemeth","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e0158746","DOI":"10.1371\/journal.pone.0158746","article-title":"Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model","volume":"11","author":"Urbanek","year":"2016","journal-title":"PLoS ONE"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/cea.12411","article-title":"Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma","volume":"44","author":"Trzil","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"B85","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1177\/1098612X15604351","article-title":"Intravenous adipose-derived mesenchymal stem cell therapy for the treatment of feline asthma: a pilot study","volume":"18","author":"Trzil","year":"2016","journal-title":"J Feline Med Surg"},{"key":"B86","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.2147\/COPD.S146671","article-title":"Mesenchymal stromal cell therapy in COPD: from bench to bedside","volume":"12","author":"Antunes","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B87","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13287-016-0398-9","article-title":"Evaluation of amniotic mesenchymal cell derivatives on cytokine production in equine alveolar macrophages: an in vitro approach to lung inflammation","volume":"7","author":"Zucca","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"key":"B89","doi-asserted-by":"publisher","first-page":"895","DOI":"10.7326\/0003-4819-143-12-200512200-00007","article-title":"New concepts in the pathophysiology of inflammatory bowel disease","volume":"143","author":"Bamias","year":"2005","journal-title":"Ann Intern Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Pro-inflammatory cytokines in the pathogenesis of IBD","volume":"140","author":"Strober","year":"2011","journal-title":"Gastroenterology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1939-1676.2000.tb01164.x","article-title":"Chronic idiopathic inflammatory bowel diseases of the horse","volume":"14","author":"Schumacher","year":"2000","journal-title":"J Vet Intern Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e0148568","DOI":"10.1371\/journal.pone.0148568","article-title":"Th17 pathway as a target for multipotent stromal cell therapy in dogs: implications for translational research","volume":"11","author":"Kol","year":"2016","journal-title":"PLoS ONE"},{"key":"B93","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tvjl.2015.07.003","article-title":"Expression of T helper type 17 (Th17)-associated cytokines and toll-like receptor 4 and their correlation with Foxp3 positive cells in rectal biopsies of horses with clinical signs of inflammatory bowel disease","volume":"206","author":"Olofsson","year":"2015","journal-title":"Vet J"},{"key":"B94","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4161\/gmic.19344","article-title":"Systemic antibody responses to gut microbes in health and disease","volume":"3","author":"Zimmermann","year":"2012","journal-title":"Gut Microb"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e0220522","DOI":"10.1371\/journal.pone.0220522","article-title":"Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease","volume":"14","author":"Soontararak","year":"2019","journal-title":"PLoS ONE"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1089\/scd.2014.0128","article-title":"Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions","volume":"23","author":"Kol","year":"2014","journal-title":"Stem Cells Dev"},{"key":"B97","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1586\/eci.10.27","article-title":"Stem cell treatment for Crohn's disease","volume":"6","author":"Panes","year":"2010","journal-title":"Exp Rev Clin Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cveq.2005.12.030","article-title":"Infiltrative intestinal disease","volume":"22","author":"Barr","year":"2006","journal-title":"Vet Clin North Am Equine Pract"},{"key":"B99","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1939-1676.2003.tb02450.x","article-title":"A scoring index for disease activity in canine inflammatory bowel disease","volume":"17","author":"Jergens","year":"2003","journal-title":"J Vet Intern Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","article-title":"Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses","volume":"136","author":"Gonzalez","year":"2009","journal-title":"Gastroenterology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/sctm.17-0305","article-title":"Mesenchymal Stem Cells (MSC) derived from Induced Pluripotent Stem Cells (iPSC) equivalent to adipose-derived MSC in promoting intestinal healing and microbiome normalization in mouse inflammatory bowel disease model","volume":"7","author":"Soontararak","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1177\/1098612X14561105","article-title":"Stem cell therapy in cats with chronic enteropathy: a proof-of-concept study","volume":"17","author":"Webb","year":"2015","journal-title":"J Feline Med Surg"},{"key":"B103","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tvjl.2015.08.003","article-title":"Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: clinical and laboratory outcomes","volume":"206","author":"Perez-Merino","year":"2015","journal-title":"Vet J."},{"key":"B104","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tvjl.2015.07.023","article-title":"Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: endoscopic and histological outcomes","volume":"206","author":"Perez-Merino","year":"2015","journal-title":"Vet J"},{"key":"B105","first-page":"1169","article-title":"In vivo transplantation of bone marrow mesenchymal stem cells accelerates repair of injured gastric mucosa in rats","volume":"125","author":"Chang","year":"2012","journal-title":"Chinese Med J"},{"key":"B106","doi-asserted-by":"publisher","first-page":"18228","DOI":"10.3748\/wjg.v20.i48.18228","article-title":"Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?","volume":"20","author":"Goncalves Fda","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/scrt142","article-title":"Novel mechanism for mesenchymal stem cells in attenuating peritoneal adhesion: accumulating in the lung and secreting tumor necrosis factor alpha-stimulating gene-6","volume":"3","author":"Wang","year":"2012","journal-title":"Stem Cell Res. Ther"},{"key":"B108","doi-asserted-by":"crossref","first-page":"p. 369","DOI":"10.1002\/9781119047919.ch8","article-title":"Diseases of the uvea, uveitis, and recurrent uveitis","volume-title":"Equine Ophthalmology.","author":"Gilger","year":"2016"},{"key":"B109","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0165-2427(99)00082-3","article-title":"Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis","volume":"71","author":"Gilger","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1463-5224.2011.00951.x","article-title":"Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis","volume":"15","author":"Regan","year":"2012","journal-title":"Vet Ophthalmol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cveq.2004.04.010","article-title":"Equine recurrent uveitis: new methods of management","volume":"20","author":"Gilger","year":"2004","journal-title":"Vet Clin North Am Equine Pract"},{"key":"B112","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1167\/iovs.14-14788","article-title":"Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats","volume":"55","author":"Zhang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/VMRR.S66705","article-title":"Immune-mediated keratoconjunctivitis sicca in dogs: current perspectives on management","volume":"6","author":"Dodi","year":"2015","journal-title":"Vet Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3727\/215517916X693366","article-title":"Allogeneic mesenchymal stem cell transplantation in dogs with keratoconjunctivitis sicca","volume":"8","author":"Bittencourt","year":"2016","journal-title":"Cell Med."},{"key":"B115","doi-asserted-by":"crossref","first-page":"p. 252","DOI":"10.1002\/9781119047919.ch7","article-title":"Diseases of the cornea","volume-title":"Equine Ophthalmology","author":"Brooks","year":"2016"},{"key":"B116","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/vop.12641","article-title":"Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: a case series","volume":"22","author":"Davis","year":"2019","journal-title":"Vet Ophthalmol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/jcp.22953","article-title":"Blood derived stem cells: an ameliorative therapy in veterinary ophthalmology","volume":"227","author":"Marfe","year":"2012","journal-title":"J Cell Physiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13287-017-0577-3","article-title":"Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro","volume":"8","author":"Sherman","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"B119","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","article-title":"Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice","volume":"106","author":"Eliopoulos","year":"2005","journal-title":"Blood"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2746\/042516408X276942","article-title":"Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study","volume":"40","author":"Guest","year":"2008","journal-title":"Equine Vet J"},{"key":"B122","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13287-017-0503-8","article-title":"Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model","volume":"8","author":"Joswig","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"B123","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12917-016-0692-x","article-title":"Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints","volume":"12","author":"Ardanaz","year":"2016","journal-title":"BMC Vet Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/evj.12992","article-title":"Retrospective analysis of local injection site adverse reactions associated with 230 allogenic administrations of bone marrow-derived mesenchymal stem cells in 164 horses","volume":"51","author":"Ursini","year":"2019","journal-title":"Equine Vet J"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3109\/14653249.2011.602338","article-title":"Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions","volume":"13","author":"Carrade","year":"2011","journal-title":"Cytotherapy."},{"key":"B126","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13287-015-0053-x","article-title":"Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo","volume":"6","author":"Pezzanite","year":"2015","journal-title":"Stem Cell Res Ther."},{"key":"B127","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2174\/1574888X09666140220003847","article-title":"Intravenous application of allogenic peripheral blood-derived mesenchymal stem cells: a safety assessment in 291 equine recipients","volume":"9","author":"Broeckx","year":"2014","journal-title":"Curr Stem Cell Res Ther."},{"key":"B128","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13287-015-0050-0","article-title":"Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses","volume":"6","author":"Kol","year":"2015","journal-title":"Stem Cell Res Ther."},{"key":"B129","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fvets.2016.00056","article-title":"Response to intravenous allogeneic equine cord blood-derived mesenchymal stromal cells administered from chilled or frozen state in serum and protein-free media","volume":"3","author":"Williams","year":"2016","journal-title":"Front Vet Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"239","DOI":"10.15283\/ijsc16011","article-title":"Intramuscular transplantation of allogeneic mesenchymal stromal cells derived from equine umbilical cord","volume":"9","author":"Dias","year":"2016","journal-title":"Int J Stem Cells."},{"key":"B131","doi-asserted-by":"publisher","first-page":"5830103","DOI":"10.1155\/2016\/5830103","article-title":"Allogeneic mesenchymal stem cell treatment induces specific alloantibodies in horses","volume":"2016","author":"Owens","year":"2016","journal-title":"Stem Cells Int"},{"key":"B132","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/evj.12647","article-title":"Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies","volume":"49","author":"Berglund","year":"2017","journal-title":"Equine Vet J"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetimm.2018.04.004","article-title":"Differentiation of equine bone marrow derived mesenchymal stem cells increases the expression of immunogenic genes","volume":"200","author":"Barrachina","year":"2018","journal-title":"Vet Immunol Immunopathol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/evj.12142","article-title":"In vitro analysis of equine, bone marrow-derived mesenchymal stem cells demonstrates differences within age- and gender-matched horses","volume":"46","author":"Carter-Arnold","year":"2014","journal-title":"Equine Vet J"},{"key":"B135","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/scrt198","article-title":"Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies","volume":"4","author":"Quimby","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1111\/jvim.14798","article-title":"Long-term management with adipose tissue-derived mesenchymal stem cells and conventional treatment in a dog with hepatocutaneous syndrome","volume":"31","author":"Nam","year":"2017","journal-title":"J Vet Intern Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3389\/fimmu.2017.01626","article-title":"Anti-donor immune responses elicited by allogeneic mesenchymal stem cells and their extracellular vesicles: are we still learning?","volume":"8","author":"Lohan","year":"2017","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3324\/haematol.11446","article-title":"No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients","volume":"92","author":"Sundin","year":"2007","journal-title":"Haematologica"},{"key":"B140","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12015-015-9638-0","article-title":"Canine and equine mesenchymal stem cells grown in serum free media have altered immunophenotype","volume":"12","author":"Clark","year":"2016","journal-title":"Stem Cell Rev Rep"},{"key":"B141","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.tvjl.2013.04.018","article-title":"Therapeutic use of stem cells in horses: which type, how, and when?","volume":"197","author":"Schnabel","year":"2013","journal-title":"Vet J."},{"key":"B142","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/cvr\/cvr113","article-title":"Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease","volume":"91","author":"van der Spoel","year":"2011","journal-title":"Cardiovasc Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"567","DOI":"10.21037\/jss.2017.10.06","article-title":"Does timing of transplantation of neural stem cells following spinal cord injury affect outcomes in an animal model?","volume":"3","author":"Cheng","year":"2017","journal-title":"J Spine Surg."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fvets.2019.00507\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T11:50:47Z","timestamp":1722340247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fvets.2019.00507\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":143,"alternative-id":["10.3389\/fvets.2019.00507"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2019.00507","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,21]]},"article-number":"507"}}